COVID-19

COVID-19 research covers pathway and target studies, drug development for specific targets, and vaccine development. It has been the primary focus for scientists around the world as we race to end this global pandemic. With emerging variants, the study for both drug development as well as vaccine development has required variant specific testing as well. Already, there are several vaccines both in the market, as well as in pre-clinical and clinical development stages. 

Krishgen ELISA for COVID-19 supports the researcher at every stage – from discovery to trials. With over 70 ELISA, the world’s largest range of assays for Coronavirus, Krishgen ELISA bridge the gap from animal to human studies.

Our Covid-19 Assays are being used by leading Vaccine Companies both in India and globally for Assay Titer Checks, Antibody Monitoring, Neutralisation Studies and Mutation Variant Checks.

These kits are separated as per their function:

1. Human COVID-19 Antigen detection ELISA

2. Human COVID-19 Antibody detection ELISA

3. Animal COVID-19 antigen or antibody detection ELISA (Rat, Mouse etc)

4. Neutralizing Antibody Estimation ELISA

5. Cytokine Storm Monitoring ELISA

6. Other pathway biomarkers ELISA

Why Krishgen COVID-19 ELISA?

•Robust, sensitive assays available for specific research

•Lot-to-lot consistency with Precision CV <15>

•Thoroughly validated; where possible, using the NIBSC / WHO COVID-19 antibodies reference panel

•In stock, and priced competitively
 

Krishgen manufactures some of the most unique ELISA in the world for COVID-19 research, and can also custom develop an ELISA for you. 

ELISA available for Vaccine and Therapy Research and Development by target

1. Spike RBD Protein